News and Events

High cholesterol patients in BC at increased risk! Help support with request to Minister of Health or BC Legislative Member

July 21, 2016

BC is one of the few provinces (indeed places in the world) where Ezetrol (ezetimibe) is NOT listed as a drug benefit for patients whose.

New Cholesterol Treatment Now Available for Canadians As 8 in 10 Canadian GPs identify the need for new cholesterol treatment options, Canadian Patients now have access to PRALUENT™

May 25, 2016

Montreal, Quebec, May 24, 2016 – Sanofi Canada is pleased to announce that PRALUENT (alirocumab), solution for subcutaneous injection, is now available in Canada for.

NEWS RELEASE: NEW STUDY RESULTS OF REPATHA®™ (EVOLOCUMAB) IN STATIN-INTOLERANT PATIENTS PUBLISHED IN JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

April 6, 2016

Amgen Canada Inc. 6775 Financial Dr. Mississauga , ON L5N 0A4 Telephone 905-285-3000 www.Amgen.ca NEW STUDY RESULTS OF REPATHA®™ (EVOLOCUMAB) IN STATIN-INTOLERANT PATIENTS PUBLISHED IN JOURNAL OF.

Join us: FH Canada Patient & Family Conference in Vancouver on April 23, 2016 at the Metropolitan Hotel

March 18, 2016

FH Canada Network Agenda_April 23.

High cholesterol patients in BC at increased risk! Help support with request to Minister of Health or BC Legislative Member

New Cholesterol Treatment Now Available for Canadians As 8 in 10 Canadian GPs identify the need for new cholesterol treatment options, Canadian Patients now have access to PRALUENT™

NEWS RELEASE: NEW STUDY RESULTS OF REPATHA®™ (EVOLOCUMAB) IN STATIN-INTOLERANT PATIENTS PUBLISHED IN JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Join us: FH Canada Patient & Family Conference in Vancouver on April 23, 2016 at the Metropolitan Hotel

ASCVD (coronary artery disease) Questionnaire

Request for Personal Feedback

Patient Feedback on NEW treatment for High Cholesterol